Latest / Journal of the American Academy of Child and Adolescent Psychiatry
Attention-Deficit/Hyperactivity Disorder Subtypes Defined by Cognition Have a Distinct Neural and Clinical Profile and Differ in Response to Atomoxetine: JAACAP May 2026
May 2026: Contributing Editor Deepika Shaligram interviews John E. Leikauf on a study that identified new attention-deficit/hyperactivity disorder (ADHD) subtypes using computerized attention-based tasks and compared these new subtypes’ responses to 2 ADHD medications: methylphenidate (stimulant) and atomoxetine (nonstimulant).
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.